CastleVax
Jori Horberg is the Director of Operations at CastleVax. Prior to this role, Jori held positions as an Investor at Oula and Elektra Health. Jori also served as a Venture Fellow at January Ventures, a Senior Associate at Guidehouse, and an Advisory Associate at PwC. Jori has a Bachelor of Science in Business with a focus on Finance from NYU Stern School of Business.
This person is not in any teams
This person is not in any offices
CastleVax
CastleVax is the proven technology that will bring safe vaccines for all humans, everywhere. Our state-of-the-art platform for producing first-in-class vaccines uses Newcastle Disease Virus (NDV) to enable rapid development of safe and highly immunogenic viral vectors that are easy to deliver and store, and can be administered via injection or intranasally.